Inpatient and Outpatient Orderable

Neuron-specific Enolase (NSE)

Synonyms

  • LAB10906
  • NEURON SPECIFIC ENOLASE

Cerner Name

Neuron Specific Enolase

Clinical Info

An aid in the detection and monitoring of neuroendocrine tumors (NETs), particularly those associatedwith small-cell lung cancer (SCLC)

Specimen Sources

Blood, Arterial Blood, Capillary Blood, Central Line Blood, Venous

Specimen Types

Blood

Specimen Volume

0.5 mL serum ( 0.3 mL min)

Container

Red Top Tube

Collection Instructions

Container/Tube: Gold top or Red Top Tube
Specimen: 0.5 mL serum ( 0.3 mL min)
Transport Temperature: Refrigerated
Stability: 7 Days Room Temperature or Refrigerated
               14 Days Frozen
Collection   Transfer separated serum to a plastic transport tube as quickly as possible after the clot has formed (within 30 minutes of collection).

Transport Instructions

Refrigerated

Specimen Stability

7 Days Room Temperature or Refrigerated
               14 Days Frozen
Collection   Transfer separated serum to a plastic transport tube as quickly as possible after the clot has formed (within 30 minutes of collection).

Methodology

The ThermoFisher/BRAHMS KRYPTOR® assay employs Time-Resolved Amplified CryptateEmission (TRACE) technology based on a non-radioactive energy transfer between a donor(europium cryptate) and an acceptor (XL665) in a sandwich immunofluorescent format using twomouse monoclonal antibodies.

Days Performed

Performing Laboratory

LabCorp

CPT

86316
 
LOINC Code: 57371-7

PDM

5900176

Only Orderable at Locations:

Orderable Everywhere

Results
Component Name Base Name Common Name External Name
NEURON SPECIFIC ENOLASE NEUROSPENO NEURON SPECIFIC ENOLASE Neuron-specific Enolase, Serum

Result Interpretation

0.0 -17.6  ng/mL
 
Results of this test are labeled for research purposes only by the assay's
manufacturer. The performance characteristics of this assay have not been
established by the manufacturer. The result should not be used for treatment
or for diagnostic purposes without confirmation of the diagnosis by another
medically established diagnostic product or procedure. The performance
characteristics were determined by LabCorp.
 
TAT: 7 - 10 Days

Forms
LAB10906 build edit